Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Simethicone with PEG

Preclinical

DDalin Tzu Chi General Hospital

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Bowel PreparationNot yet recruiting

Bowel PreparationPreclinical

Not yet recruiting

Timeline

Expected Milestones

Q3 2028

PreclinicalNot yet recruiting

Bowel Preparation

NCT07674160

Clinical

Trials by Indication[1]

Bowel Preparation1 trial

Effects of Simethicone on Colon Preparation in Water Exchange Colonoscopies: a Randomized Controlled Study

Not yet recruiting·DDalin Tzu Chi General Hospital·Preclinical·NCT07674160·180 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Simethicone with PEG. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Simethicone with PEG. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Dalin Tzu Chi General Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: DDalin Tzu Chi General Hospital

Related News